immatics biotechnologies GmbH (4A3) — Free Cash Flow Generation Index
immatics biotechnologies GmbH (4A3) has a Free Cash Flow Generation Index of 0.88x as of December 2023. Free cash flow of €69.78 Million represents 1% of operating cash flow (€79.08 Million). Explore reinvestment intensity of immatics biotechnologies GmbH to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
immatics biotechnologies GmbH Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for immatics biotechnologies GmbH across 6 annual periods. For the full cash flow conversion analysis, see immatics biotechnologies GmbH (4A3) cash flow conversion.
Annual Free Cash Flow Generation for immatics biotechnologies GmbH (2018–2023)
Year-by-year Free Cash Flow Generation Index for immatics biotechnologies GmbH. Check immatics biotechnologies GmbH cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.70x | €-12.73 Million | €18.23 Million | €30.96 Million | ▼ -174.5% |
| 2022 | 0.94x | €93.92 Million | €100.13 Million | €5.74 Million | ▲ +207.4% |
| 2021 | -0.87x | €-87.44 Million | €100.13 Million | €5.11 Million | ▲ +6.1% |
| 2020 | -0.93x | €-93.13 Million | €100.13 Million | €7.42 Million | ▼ -196.0% |
| 2019 | 0.97x | €68.73 Million | €70.97 Million | €2.14 Million | ▼ -0.7% |
| 2018 | 0.98x | €20.18 Million | €20.68 Million | €429.00K | — |